share_log

Tenet Healthcare's (NYSE:THC) Promising Earnings May Rest On Soft Foundations

Tenet Healthcare's (NYSE:THC) Promising Earnings May Rest On Soft Foundations

Tenet Healthcare(紐約證券交易所代碼:THC)承諾的收益可能取決於軟基礎
Simply Wall St ·  05/07 06:45

Unsurprisingly, Tenet Healthcare Corporation's (NYSE:THC) stock price was strong on the back of its healthy earnings report. However, our analysis suggests that shareholders may be missing some factors that indicate the earnings result was not as good as it looked.

毫不奇怪,Tenet Healthcare Corporation(紐約證券交易所代碼:THC)的股價因其健康的收益報告而表現強勁。但是,我們的分析表明,股東可能遺漏了一些表明盈利業績不如預期的因素。

earnings-and-revenue-history
NYSE:THC Earnings and Revenue History May 7th 2024
紐約證券交易所:THC 收益和收入歷史記錄 2024 年 5 月 7 日

How Do Unusual Items Influence Profit?

不尋常的物品如何影響利潤?

Importantly, our data indicates that Tenet Healthcare's profit received a boost of US$2.0b in unusual items, over the last year. We can't deny that higher profits generally leave us optimistic, but we'd prefer it if the profit were to be sustainable. We ran the numbers on most publicly listed companies worldwide, and it's very common for unusual items to be once-off in nature. And, after all, that's exactly what the accounting terminology implies. Tenet Healthcare had a rather significant contribution from unusual items relative to its profit to March 2024. All else being equal, this would likely have the effect of making the statutory profit a poor guide to underlying earnings power.

重要的是,我們的數據表明,與去年相比,Tenet Healthcare的不尋常項目利潤增加了20億美元。我們不能否認更高的利潤通常會讓我們感到樂觀,但如果利潤是可持續的,我們更願意這樣做。我們統計了全球大多數上市公司的數字,不尋常的物品在自然界中很常見。而且,畢竟,這正是會計術語的含義。截至2024年3月,Tenet Healthcare從不尋常的項目中獲得了相當大的利潤。在其他條件相同的情況下,這可能會使法定利潤成爲衡量潛在盈利能力的不良指導。

That might leave you wondering what analysts are forecasting in terms of future profitability. Luckily, you can click here to see an interactive graph depicting future profitability, based on their estimates.

這可能會讓你想知道分析師對未來盈利能力的預測。幸運的是,您可以單擊此處查看根據他們的估計描繪未來盈利能力的交互式圖表。

Our Take On Tenet Healthcare's Profit Performance

我們對Tenet Healthcare利潤表現的看法

As we discussed above, we think the significant positive unusual item makes Tenet Healthcare's earnings a poor guide to its underlying profitability. As a result, we think it may well be the case that Tenet Healthcare's underlying earnings power is lower than its statutory profit. But the good news is that its EPS growth over the last three years has been very impressive. At the end of the day, it's essential to consider more than just the factors above, if you want to understand the company properly. If you want to do dive deeper into Tenet Healthcare, you'd also look into what risks it is currently facing. To help with this, we've discovered 4 warning signs (1 shouldn't be ignored!) that you ought to be aware of before buying any shares in Tenet Healthcare.

正如我們上面討論的那樣,我們認爲這一重大利好不尋常的項目使Tenet Healthcare的收益無法衡量其潛在盈利能力。因此,我們認爲Tenet Healthcare的潛在盈利能力很可能低於其法定利潤。但好消息是,其在過去三年中的每股收益增長非常令人印象深刻。歸根結底,如果你想正確地了解公司,必須考慮的不僅僅是上述因素。如果你想更深入地了解Tenet Healthcare,你還需要研究它目前面臨的風險。爲了幫助解決這個問題,我們發現了 4 個警告信號(1 個不容忽視!)在購買Tenet Healthcare的任何股票之前,你應該注意這一點。

This note has only looked at a single factor that sheds light on the nature of Tenet Healthcare's profit. But there are plenty of other ways to inform your opinion of a company. For example, many people consider a high return on equity as an indication of favorable business economics, while others like to 'follow the money' and search out stocks that insiders are buying. While it might take a little research on your behalf, you may find this free collection of companies boasting high return on equity, or this list of stocks that insiders are buying to be useful.

本報告僅研究了揭示Tenet Healthcare利潤性質的單一因素。但是,還有很多其他方法可以讓你對公司的看法。例如,許多人認爲高股本回報率是有利的商業經濟的標誌,而另一些人則喜歡 “關注資金”,尋找內部人士正在買入的股票。雖然可能需要你進行一些研究,但你可能會發現這份免費收集的擁有高股本回報率的公司,或者這份內部人士正在購買的股票清單很有用。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?對內容感到擔憂?直接聯繫我們。 或者,給編輯團隊 (at) simplywallst.com 發送電子郵件。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之,華爾街沒有持有任何上述股票的頭寸。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論